ISSN Print 2500–1094
ISSN Online 2542–1204
BIOMEDICAL JOURNAL OF PIROGOV UNIVERSITY (MOSCOW, RUSSIA)
Copyright: © 2020 by the authors. Licensee: Pirogov University.
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (CC BY).
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (CC BY).
ORIGINAL RESEARCH
Efficiency of the gynecologic malignancies identification measures at the level of primary health care
About authors
1 South Ural State Medical University, Chelyabinsk, Russia
2 Russian Scientific Center for Roentgenoradiology, Moscow, Russia
3 Clinical Center of Oncology and Nuclear Medicine of Chelyabinsk Region, Chelyabinsk, Russia
Correspondence should be addressed: Anna G. Bochkova
Dovatora, 23, Chelyabinsk, 454091; ur.liam@6947avokhcobanna
About paper
Author contribution: Bochkova AG — research planning, manuscript writing, data acquisition, data analysis and interpretation, literature analysis; Domozhirova AS — research planning, data analysis and interpretation, manuscript editing; Aksenovа IA — data acquisition, manuscript writing.
Received: 2019-12-23
Accepted: 2020-01-08
Published online: 2020-01-23
|
Fig. 1. Dynamics of the I/II stage cervical cancer (C53) proportion in patients identified actively in the patient examination rooms compared with the average rate for
Chelyabinsk Region in 2010-2017, %
Fig. 2. Dynamics of the I/II stage uterine corpus cancer (С54) proportion in patients identified actively in the patient examination rooms compared with the average rate for Chelyabinsk Region in 2010–2017, %
Fig. 3. Dynamics of the I/II stage ovarian cancer (С56) proportion in patients identified actively in the patient examination rooms compared with the average rate for
Chelyabinsk Region in 2010–2017, %
Fig. 4. Adjusted cumulative survival in cervical cancer patients (С53) of the treatment and control groups (PBCR of the Chelyabinsk Region database, 2005–2015), %
Fig. 5. Adjusted cumulative survival in uterine corpus cancer patients (С54) of the treatment and control groups (PBCR of the Chelyabinsk Region database, 2005–2015), %
Fig. 6. Adjusted cumulative survival in ovarian cancer patients (С56) of the treatment and control groups (PBCR of the Chelyabinsk Region database, 2005–2015), %
Table 1. Stage distribution in cervical cancer patients (С53) of the treatment and control groups according to the FIGO system (2009)
Table 2. Stage distribution in uterine corpus cancer patients (С54) of the treatment and control groups according to the FIGO system (2009)
Table 3. Stage distribution in ovarian cancer patients (С56)of the treatment and control groups according to the FIGO system (2009)
